Immunogenicity and safety of a hexavalent pediatric vaccine in HIV-exposed infected and uninfected infants in Republic of South Africa
Human immunodeficiency virus (HIV)-exposed infants may be at increased risk of vaccine-preventable disease. This study was conducted as a post-licensure commitment in this population to evaluate the primary series, antibody persistence, and booster response to a licensed fully liquid hexavalent vacc...
Main Authors: | Anthonet Koen, Shabir Madhi, Olga Lyabis, Emmanuel Vidor, Beverley Cowper, Thinus Marais, Dhaval Patel, Claire Vigne |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-06-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2020.1839289 |
Similar Items
-
Pneumococcal conjugate vaccine in HIV-infected and HIV-exposed, uninfected children
by: Sabelle Jallow, et al.
Published: (2017-05-01) -
Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines in healthy infants in India
by: S. Mangarule, et al.
Published: (2022-04-01) -
Clinical and immunological outcomes of HIV-exposed uninfected and HIV-unexposed uninfected children in the first 24 months of life in Western Kenya
by: Jessica E. Ray, et al.
Published: (2024-02-01) -
Pattern of infectious morbidity in HIV exposed uninfected infants and children
by: Amy L Slogrove, et al.
Published: (2016-05-01) -
Evolution of the Gut Microbiome in HIV-Exposed Uninfected and Unexposed Infants during the First Year of Life
by: Conner L. Jackson, et al.
Published: (2022-10-01)